Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-03

FDA Approved: FLECAINIDE ACETATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approves the original application for flecainide acetate by Rising Pharma Holdings, Inc., providing a generic antiarrhythmic product. Indications include ma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flecainide acetate (flecainide acetate)

Snippet

ORIG AP for FLECAINIDE ACETATE (FLECAINIDE ACETATE)